MAPK3 and lymphoma: Interestingly, TRIM65 was shown to downregulate NLRP3 inflammasome activation [156], while in the setting of lymphoma, TRIM65 overexpression favors lymphoma cell survival via the ERK1/2 signaling pathway [171].